Ipsen SA Net Income Growth & History (IPN)
Ipsen SA's net income was €443.5M for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €443.5M | €96.2M | +27.70% |
| 2024 | 2024-12-31 | €347.3M | −€299.9M | −46.34% |
| 2023 | 2023-12-31 | €647.2M | −€300,000 | −0.05% |
| 2022 | 2022-12-31 | €647.5M | €800,000 | +0.12% |
| 2021 | 2021-12-31 | €646.7M | €97.8M | +17.82% |
| 2020 | 2020-12-31 | €548.9M | — | — |
Ipsen SA net income trends
Over the last five fiscal years, Ipsen SA's net income decreased from €548.9M to €443.5M, a change of −€105.4M.
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company official filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...